266 related articles for article (PubMed ID: 25148294)
21. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
22. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
Pitta SK; Dudhipala N; Narala A; Veerabrahma K
Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
[TBL] [Abstract][Full Text] [Related]
23. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.
Ammar HO; Mohamed MI; Tadros MI; Fouly AA
AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503
[TBL] [Abstract][Full Text] [Related]
24. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
25. Transdermal film-loaded finasteride microplates to enhance drug skin permeation: Two-step optimization study.
Ahmed TA; El-Say KM
Eur J Pharm Sci; 2016 Jun; 88():246-56. PubMed ID: 26993962
[TBL] [Abstract][Full Text] [Related]
26. Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application:
Dudhipala N; Phasha Mohammed R; Adel Ali Youssef A; Banala N
Drug Dev Ind Pharm; 2020 Aug; 46(8):1334-1344. PubMed ID: 32598194
[TBL] [Abstract][Full Text] [Related]
27. Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.
Duangjit S; Opanasopit P; Rojanarata T; Ngawhirunpat T
J Drug Deliv; 2011; 2011():418316. PubMed ID: 21490750
[TBL] [Abstract][Full Text] [Related]
28. Bootstrap resampling technique to evaluate the reliability of the optimal liposome formulation: skin permeability and stability response variables.
Duangjit S; Opanasopit P; Rojanarata T; Takayama J; Takayama K; Ngawhirunpat T
Biol Pharm Bull; 2014; 37(9):1543-9. PubMed ID: 25008239
[TBL] [Abstract][Full Text] [Related]
29. Transfersomes--a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation.
Jain S; Jain P; Umamaheshwari RB; Jain NK
Drug Dev Ind Pharm; 2003 Oct; 29(9):1013-26. PubMed ID: 14606665
[TBL] [Abstract][Full Text] [Related]
30. Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization.
Shamma RN; Elsayed I
J Liposome Res; 2013 Sep; 23(3):244-54. PubMed ID: 23713516
[TBL] [Abstract][Full Text] [Related]
31. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
[TBL] [Abstract][Full Text] [Related]
32. Experimental Design Based Optimization and Ex Vivo Permeation of Desmopressin Acetate Loaded Elastic Liposomes Using Rat Skin.
Altamimi MA; Hussain A; Alshehri S; Imam SS
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371738
[TBL] [Abstract][Full Text] [Related]
33. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.
El Zaafarany GM; Awad GA; Holayel SM; Mortada ND
Int J Pharm; 2010 Sep; 397(1-2):164-72. PubMed ID: 20599487
[TBL] [Abstract][Full Text] [Related]
34. Design of transfersomal nanocarriers of nystatin for combating vulvovaginal candidiasis; A different prospective.
Hady MA; Darwish AB; Abdel-Aziz MS; Sayed OM
Colloids Surf B Biointerfaces; 2022 Mar; 211():112304. PubMed ID: 34959094
[TBL] [Abstract][Full Text] [Related]
35. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
Al Shuwaili AH; Rasool BK; Abdulrasool AA
Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505
[TBL] [Abstract][Full Text] [Related]
36. Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: preparation, characterization and in vitro human skin transport study.
Dubey V; Mishra D; Nahar M; Jain NK
Curr Drug Deliv; 2008 Jul; 5(3):199-206. PubMed ID: 18673263
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.
Duangjit S; Opanasopit P; Rojanarata T; Ngawhirunpat T
AAPS PharmSciTech; 2013 Mar; 14(1):133-40. PubMed ID: 23242556
[TBL] [Abstract][Full Text] [Related]
38. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study.
Imam SS; Aqil M; Akhtar M; Sultana Y; Ali A
Drug Deliv; 2015 Dec; 22(8):1059-1070. PubMed ID: 24471715
[TBL] [Abstract][Full Text] [Related]
39. Preparation and quality assessment of itraconazole transfersomes.
Zheng WS; Fang XQ; Wang LL; Zhang YJ
Int J Pharm; 2012 Oct; 436(1-2):291-8. PubMed ID: 22796030
[TBL] [Abstract][Full Text] [Related]
40. Formulation and characterization of Phospholipon 90 G and tween 80 based transfersomes for transdermal delivery of eprosartan mesylate.
Ahad A; Al-Saleh AA; Al-Mohizea AM; Al-Jenoobi FI; Raish M; Yassin AEB; Alam MA
Pharm Dev Technol; 2018 Oct; 23(8):787-793. PubMed ID: 28504046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
